Koninklijke Philips (PHIA) – Research Analysts’ Weekly Ratings Updates

Koninklijke Philips (AMS: PHIA) recently received a number of ratings updates from brokerages and research firms:

  • 9/10/2021 – Koninklijke Philips was given a new €53.00 ($62.35) price target on by analysts at Barclays PLC.
  • 9/8/2021 – Koninklijke Philips was given a new €43.00 ($50.59) price target on by analysts at Deutsche Bank Aktiengesellschaft.
  • 9/8/2021 – Koninklijke Philips was given a new €55.00 ($64.71) price target on by analysts at Jefferies Financial Group Inc..
  • 8/31/2021 – Koninklijke Philips was given a new €53.00 ($62.35) price target on by analysts at The Goldman Sachs Group, Inc..
  • 7/28/2021 – Koninklijke Philips was given a new €53.00 ($62.35) price target on by analysts at UBS Group AG.
  • 7/26/2021 – Koninklijke Philips was given a new €52.00 ($61.18) price target on by analysts at The Goldman Sachs Group, Inc..
  • 7/26/2021 – Koninklijke Philips was given a new €52.00 ($61.18) price target on by analysts at Berenberg Bank.

Koninklijke Philips NV has a fifty-two week low of €28.92 ($34.02) and a fifty-two week high of €36.12 ($42.49).

Koninklijke Philips N.V. is the Netherlands-based health technology company. The Company’s segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease.

Recommended Story: Why does the United States have a lingering trade deficit?

Receive News & Ratings for Koninklijke Philips NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips NV and related companies with MarketBeat.com's FREE daily email newsletter.